Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

Cited by (662)

Items 301–400 of 662

1. Characterization of Intra-myocellular Lipids Using 2d Localized Correlated Spectroscopy and Abdominal Fat Using Mri in Type 2 Diabetes
   Preethi Srikanthan, Aparna Singhal, Cathy C. Lee, Rajakumar Nagarajan, Neil E. Wilson, Christian K. Roberts, Theodore J. Hahn, Michael Albert Thomas · 2012 · Magnetic Resonance Insights
2. Prolonged Decrease of Adipocyte Size after Rosiglitazone Treatment in High‐ and Low‐Fat‐Fed Rats
   Julia A. Johnson, Steven E. Trasino, Anthony W. Ferrante, Joseph R. Vasselli · 2007 · Obesity
3. [Adipocitokines, adipose tissue and its relationship with immune system cells].
   Fausto Sánchez‐Muñoz, Rebeca García-Macedo, Francisco Javier Alarcón-Aguilar, Miguel Cruz · 2005 · PubMed
4. Overexpression of Galectin 3 in Pancreatic β Cells Amplifies β-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice
   Ivica Petrović, Nada N. Pejnovic, Biljana Ljujić, Sladjana M. Pavlovic, Marina Miletić Kovačević, Ilija D. Jeftic, Aleksandar Djukić, Nevena D. Draginic, Marijana M. Andjic, Nebojša Arsenijević et al. · 2020 · Frontiers in Endocrinology
5. Insulin Resistance
   Alan R. Sinaiko, Sonia Caprio · 2012 · The Journal of Pediatrics
6. Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus?
   Edward S. Horton · 2008 · Endocrine Practice
7. Reduction of Free Fatty Acids, Safety, and Pharmacokinetics of Oral GS‐9667, an A1 Adenosine Receptor Partial Agonist
   Peter Staehr, Arvinder K. Dhalla, Julia Zack, Xuegong Wang, Yu Liu Ho, Justus Bingham, Luiz Belardinelli · 2013 · The Journal of Clinical Pharmacology
8. The Relationship between Atherogenic Index of Plasma and Obesity among Adults in Taiwan
   Jen-Shan Zhang, Wei-Chung Yeh, Yi-Wen Tsai, Jau‐Yuan Chen · 2022 · International Journal of Environmental Research and Public Health
9. Renin Angiotensin System and Cardiovascular Disease
   W DEMELLO, Edward David Frohlich · 2009 · Humana Press eBooks
10. Tenomodulin is Associated with Obesity and Diabetes Risk: The Finnish Diabetes Prevention Study
    Anna‐Maija Tolppanen, Leena Pulkkinen, Marjukka Kolehmainen, Ursula Schwab, Jaana Lindström, Jaakko O. Tuomilehto, Matti I.J. Uusitupa, For the Finnish Diabetes Prevention Study Group · 2007 · Obesity
11. Effects of the Insulin-Sensitizing Drug Pioglitazone and Lipopolysaccharide Administration on Insulin Sensitivity in Horses
    Jessica K. Suagee, B.A. Corl, Jamie G. Wearn, Mark V. Crisman, Matthew W. Hulver, Raymond J. Geor, L. Jill McCutcheon · 2011 · Journal of Veterinary Internal Medicine
12. Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea
    Curtis L. Triplitt, Leonard C. Glass, Yoshiniro Miyazaki, Estela Wajcberg, Amalia Gastaldelli, Eleanna De Filippis, Eugênio Cersósimo, Ralph A. DeFronzo · 2006 · Diabetes Care
13. Testosterone deficiency and the metabolic syndrome
    Bruno Lunenfeld · 2007 · The Aging Male
14. Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype
    Woo‐Keun Seo, Juyeon Kim, Yoo Hwan Kim, Ji Hyun Kim, Kyungmi Oh, Seong‐Beom Koh, Hong Seog Seo · 2011 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
15. Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells
    Qing Liu, Seon Beom Kim, Jong Hoon Ahn, Bang Yeon Hwang, Sung Yeon Kim, Mi Kyeong Lee · 2011 · Natural Product Research
16. Identification of Differentially Expressed Genes in Breast Muscle and Skin Fat of Postnatal Pekin Duck
    Tieshan Xu, Lihong Gu, Kyle M. Schachtschneider, Xiaolin Liu, Wei Huang, Ming Xie, Shuisheng Hou · 2014 · PLoS ONE
17. Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study
    Marjorie Bastien, Paul Poirier, Patrice Brassard, Benoît J. Arsenault, Olivier Francois Bertrand, Jean‐Pierre Després, Olivier Costerousse, Marie‐Ève Piché · 2019 · American Journal of Physiology-Endocrinology and Metabolism
18. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARα/γ activator
    Ramakrishna Seethala, Rajasree Golla, Zhengping Ma, Hao Zhang, Kevin O’Malley, Jonathan Lippy, Lin Cheng, Kasim A. Mookhtiar, Dennis Farrelly, Litao Zhang et al. · 2007 · Analytical Biochemistry
19. Robust signaling networks of the adipose secretome
    Rainer Breitling A · 2008 · Trends in Endocrinology and Metabolism
20. STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice
    Tatjana Sajic, Alexandre Hainard, Alexander Scherl, Annelise Wohlwend, Francesco Negro, Jean‐Charles Sanchez, Ildikó Szántó · 2013 · Scientific Reports
21. Adverse effects of noise stress on glucose homeostasis and insulin resistance in Sprague-Dawley rats
    AO Morakinyo, Titilola Aderonke Samuel, Funmileyi Olubajo Awobajo, Daniel Abiodun Adekunbi, Idowu Olufemi Olatunji, Fortune Ucheonye Binibor, Adedotun Felicia Oni · 2019 · Heliyon
22. Correlation between PPARG Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis
    Eun Jeong Jang, Da Hoon Lee, Sae-Seul Im, Jeong Yee, Hye Sun Gwak · 2023 · Pharmaceutics
23. Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes
    Sun‐Sil Choi, Byung‐Yoon Cha, Kagami Iida, Masako Sato, Young‐Sil Lee, Toshiaki Teruya, Takayuki Yonezawa, Kazuo Nagai, Je‐Tae Woo · 2011 · Journal of Natural Medicines
24. Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes
    Jodie L. Morris, Tahnee L. Bridson, Md. Abdul Alim, C. M. Rush, Donna Rudd, Brenda Govan, Natkunam Ketheesan · 2016 · Biology Open
25. Regulation of adipocyte differentiation by histone deacetylase inhibitors
    Su‐Nam Kim, Hyeyoung Choi, Yong Kee Kim · 2009 · Archives of Pharmacal Research
26. Insulin Resistance and Adolescent Girls with Polycystic Ovary Syndrome
    S.M. Bhattacharya, M. Ghosh · 2009 · Journal of Pediatric and Adolescent Gynecology
27. Adiposopathy: role of adipocyte factors in a new paradigm
    Harold Edward Bays · 2005 · Expert Review of Cardiovascular Therapy
28. Extract of Chaga mushroom (Inonotus obliquus) stimulates 3t3‐l1 adipocyte differentiation
    Jeong In Joo, Dong Hyun Kim, Jong Won Yun · 2010 · Phytotherapy Research
29. Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus
    Curtis L. Triplitt, Ralph Anthony DeFronzo · 2006 · Expert Review of Endocrinology & Metabolism
30. S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes
    Qiong He, Jiaqi Bo, Ruihua Shen, Yan Li, Yi Zhang, Jiaxin Zhang, Jing Yang, Yunfeng Liu · 2021 · Journal of Diabetes Research
31. Targeting Components of the Stress System as Potential Therapies for the Metabolic Syndrome
    Volkan Yumuk · 2006 · Annals of the New York Academy of Sciences
32. Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice
    Woojung Lee, Jungyeob Ham, Hak Cheol Kwon, Yong Kee Kim, Su‐Nam Kim · 2013 · Biochemical and Biophysical Research Communications
33. ‘Striking the Right Balance’ in Targeting PPARγ in the Metabolic Syndrome: Novel Insights from Human Genetic Studies
    Mark Gurnell · 2007 · PPAR Research
34. The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes
    Burkhard Göke, Ingrid A. M. Gause‐Nilsson, Anders Persson · 2007 · Diabetes and Vascular Disease Research
35. Acute Coffee Ingestion Does Not Affect LDL Cholesterol Level
    Rebecca J Cheung, Eric K. Gupta, Matthew K. Ito · 2005 · Annals of Pharmacotherapy
36. Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
    Ralph Anthony DeFronzo, Richard Joseph Auchus · 2025 · Diabetes
37. What are the pharmacotherapy options for treating prediabetes?
    Giuseppe Daniele, Muhammad A Abdul‐Ghani, Ralph A. DeFronzo · 2014 · Expert Opinion on Pharmacotherapy
38. A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
    Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha R. Ambwani, Surjit Singh · 2017 · Indian Journal of Clinical Biochemistry
39. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study
    Erika M. Ripley, Geoffrey D. Clarke, Vala Hamidi, ROBERT A. MARTINEZ, F Settles, Carolina Solis‐Herrera, Shengwen Deng, Muhammad A Abdul‐Ghani, Devjit Tripathy, Ralph A. DeFronzo · 2018 · American Journal of Physiology-Endocrinology and Metabolism
40. Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis
    Lucia Russo, Hilda E. Ghadieh, Simona S. Ghanem, Qusai Y. Al–Share, Zachary N. Smiley, Cara M. Gatto-Weis, Emily L. Esakov, Marcia F. McInerney, Garrett Heinrich, Xin Tong et al. · 2016 · Journal of Lipid Research
41. 8-Hydroxy-2-deoxyguanosine ameliorates high-fat diet-induced insulin resistance and adipocyte dysfunction in mice
    Joo Young Huh, Inji Jung, Lingjuan Piao, Hunjoo Ha, Myung-Hee Chung · 2017 · Biochemical and Biophysical Research Communications
42. Thiazolidinedione derivatives in type 2 diabetes mellitus.
    Cees J. Tack, Paul Smits · 2006 · PubMed
43. Adipokine Profile and C-Reactive Protein in Pregnancy: Effects of Glucose Challenge Response Versus Body Mass Index
    Johan Verhaeghe, Rita van Bree, Suzan Lambin, Silvia Caluwaerts · 2005 · Journal of the Society for Gynecologic Investigation
44. Regulation of Intermediary Metabolism During Fasting and Feeding
    Ralph Anthony DeFronzo, Ele Ferrannini · 2015 · Elsevier eBooks
45. Free Fatty Acid-Induced Insulin Resistance in the Obese Is Not Prevented by Rosiglitazone Treatment
    Sandeep Dhindsa, Devjit Tripathy, Nishanth Sanalkumar, Shreyas T. Ravishankar, Husam Ghanim, Ahmad Aljada, Paresh Dandona · 2005 · The Journal of Clinical Endocrinology & Metabolism
46. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
    David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera Martínez, David Corredor-Rengifo, Jorge E. Rico-Fontalvo, Juan Esteban Gómez‐Mesa, John Jairo Duque Ossman, Alín Abreu-Lomba · 2024 · American Journal of Cardiovascular Drugs
47. Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
    Ralph A. DeFronzo, Triplitt, Cersosimo · 2010 · Vascular Health and Risk Management
48. Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice
    Eriko Inoue, Toshihiro Ichiki, Kotaro Takeda, Hirohide Matsuura, Toru Hashimoto, Jiro Ikeda, Aya Kamiharaguchi, Kenji Sunagawa · 2012 · Journal of Endocrinology
49. Association of the leptin to high-molecular-weight adiponectin ratio with metabolic syndrome
    Ji Eu Yun, Soyoung Won, Yejin Mok, Wenying Cui, Heejin Kimm, Sun Ha Jee · 2011 · Endocrine Journal
50. Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway
    Yusuke Tsuma, Jun Mori, Takeshi Ota, Yasuhiro Kawabe, Hidechika Morimoto, Shota Fukuhara, Kazuki Kodo, Atsushi Umemura, Hisakazu Nakajima, Hajime Hosoi · 2018 · Biochemical and Biophysical Research Communications
51. A computational model of postprandial adipose tissue lipid metabolism derived using human arteriovenous stable isotope tracer data
    Shauna D. O’Donovan, Michael Lenz, Roel Vink, Nadia J. T. Roumans, Theo M. C. M. de Kok, Edwin C.M. Mariman, Ralf Peeters, Natal A. W. van Riel, Marleen A. van Baak, Ilja C.W. Arts · 2019 · PLoS Computational Biology
52. Basal Insulin: Beyond Glycemia
    Kevin Dean Niswender · 2011 · Postgraduate Medicine
53. Regulation of Insulin Clearance by Non-Esterified Fatty Acids
    Sonia Michael Najjar, Raziyeh Abdolahipour, Hilda E. Ghadieh, Marziyeh Salehi Jahromi, John A. Najjar, Basil A. M. Abuamreh, Sobia Zaidi, Sivarajan Kumarasamy, Harrison T. Muturi · 2022 · Biomedicines
54. Effects of Roux-en-Y Gastric Bypass or Diabetes Support and Education on Insulin Sensitivity and Insulin Secretion in Morbidly Obese Patients With Type 2 Diabetes
    Chin Meng Khoo, Jiegen Chen, Zehra Nurgul Pamuklar, Alfonso Torquati · 2013 · Annals of Surgery
55. Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart
    Zhenglong Liu, Jeffrey Ding, Timothy S. McMillen, Outi M. Villet, Rong Tian, Dan Shao · 2020 · Journal of Molecular and Cellular Cardiology
56. Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus
    M. MAR ROCA-RODRIGUEZ, Cristina López‐Tinoco, Álvaro Fernández‐Deudero, Mora Murri, María Victoria García‐Palacios, M. Amor García‐Valero, Francisco José Tinahones, Manuel Aguilar‐Diosdado · 2012 · Diabetes/Metabolism Research and Reviews
57. First approved inhaled insulin therapy for diabetes mellitus
    Rucha Jani, Curtis L. Triplitt, Charles A. Reasner, Ralph Anthony DeFronzo · 2006 · Expert Opinion on Drug Delivery
58. The miR-23–27–24 cluster: an emerging target in NAFLD pathogenesis
    Ru, Lin, Wang, Xiao-mei, Niu, Jun-qi · 2022 · Acta Pharmacologica Sinica
59. Development of New Zinc Dithiosemicarbazone Complex for Use as Oral Antidiabetic Agent
    Saori Kadowaki, Masayuki Munekane, Yoji Kitamura, Makoto Hiromura, Shinichiro Kamino, Yutaka Yoshikawa, Hideo Saji, Shuichi Enomoto · 2013 · Biological Trace Element Research
60. A Dual‐Response Partial Least Squares Regression QSAR Model and its Application in Design of Dual Activators of PPARα and PPARγ
    Subhash Ajmani, Sudhir A. Kulkarni · 2008 · QSAR & Combinatorial Science
61. Characterization of alendronic- and undecylenic acid coated magnetic nanoparticles for the targeted delivery of rosiglitazone to subcutaneous adipose tissue
    Katayoun Saatchi, Sarah E. Tod, Donna Leung, Kenton E. Nicholson, Irene Andreu, Christian Buchwalder, Veronika Schmitt, Urs O. Häfeli, Sarah Louise Gray · 2016 · Nanomedicine Nanotechnology Biology and Medicine
62. Diabetes Mellitus: New Challenges and Innovative Therapies
    Cristina Maria Sena, Carla F. Bento, Paulo Pereira, Filipa Marquês, Raquel Maria Fino Seiça · 2013 · Advances in predictive, preventive and personalised medicine
63. Comparison of fasting blood sugar and serum lipid profile changes after treatment with atypical antipsychotics olanzapine and risperidone.
    Jyoti Kaushal, Garima Bhutani, Rajiv Gupta · 2012 · PubMed
64. Peroxisome proliferator‐activated receptor γ agonists inhibit adipocyte expression of α1‐acid glycoprotein
    Gino A. Castriota, G. Marie Thompson, Ying Lin, Philipp E. Scherer, David E. Moller, Joel P. Berger · 2006 · Cell Biology International
65. Free fatty acid kinetics during long‐term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes
    Michael Roden, Segundo Mariz, Alessandra Rosalba Brazzale, Giovanni Pacini · 2008 · Journal of Internal Medicine
66. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases
    Su Liu, Shin-Jen Lin, Gonghui Li, Eungseok Kim, Yei‐Tsung Chen, Dong-Rong Yang, M H Eileen Tan, Eu‐Leong Yong, Chawnshang Chang · 2014 · Endocrine Related Cancer
67. Predictors of improved glycaemic control with rosiglitazone therapy in type 2 diabetic patients: a practical approach for the primary care physician
    Miyazaki, Yoshinori, De Filippis, Elena, Bajaj, Mandeep, Wajcberg, Estela, Glass, Leonard, Triplitt, Curtis, Cersosimo, Eugenio, Mandarino, Lawrence J, Defronzo, Ralph A · 2005 · The British Journal of Diabetes & Vascular Disease
68. Association between fat mass index, fat‐free mass index and hemoglobin A1c in a Japanese population: The Tohoku Medical Megabank Community‐based Cohort Study
    Masato Takase, Tomohiro Nakamura, Takumi Hirata, Naho Tsuchiya, Mana Kogure, Fumi Itabashi, Naoki Nakaya, Yohei Hamanaka, Junichi Sugawara, Kichiya Suzuki et al. · 2021 · Journal of Diabetes Investigation
69. Molecular targets for management of diabetes: Remodelling of white adipose to brown adipose tissue
    Shushmita Chand, Alok Shiomurti Tripathi, Anil P. Dewani, Naheed Waseem A. Sheikh · 2024 · Life Sciences
70. Changes in HOMA-IR index levels after bariatric surgery: Comparison of Single Anastomosis Duodenal Switch-proximal approach (SADS-p) and One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB)
    Mehmet Mahir Özmen, Cem Emir Güldoğan, Emre Gündoğdu · 2020 · International Journal of Surgery
71. Age-Dependent Development of Metabolic Derangement and Effects of Intervention with Pioglitazone in Zucker Diabetic Fatty Rats
    Zsuzsanna Szöcs, Barbara Brunmair, Karin Stadlbauer, P. Nowotny, Leonhardt Bauer, Anton Luger, Clemens Fürnsinn · 2008 · Journal of Pharmacology and Experimental Therapeutics
72. Approaches to Treatment of Type 2 Diabetes
    Zachary T. Bloomgarden · 2008 · Diabetes Care
73. Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
    Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi-Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee et al. · 2019 · Diabetes & Metabolism Journal
74. Correlation of the Dysmetabolic Risk Factors with Different Anthropometric Measurements
    Wen‐Ko Chiou, Jen‐Der Lin, Hsiao‐Fen Weng, Yung-Chun OU, Thu-Hua Liu, Ji‐Tseng Fang · 2005 · Endocrine Journal
75. A fixed-dose combination of pioglitazone and metformin:a promising alternative in metabolic control
    Jochen Seufert · 2006 · Current Medical Research and Opinion
76. Plasma non-esterified fatty acids: why are we not measuring them routinely?
    Keith N. Frayn · 2005 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
77. Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?
    Juan José Salazar, Mervin Chávez-Castillo, Joselyn Rojas, Ángel Ortega, Manuel Nava, José L. Pérez, Milagros Rojas, Cristóbal Ignacio Espinoza Díaz, Maricarmen Chacín, Yaneth Herazo et al. · 2019 · Current Diabetes Reviews
78. The Key Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk: TNF-α Down-Regulation and Improving of Insulin Resistance in HepG2 Cell Line
    Iraj Alipourfard, Salar Bakhtiyari, Ali Gheysarzadeh, Laura Di Renzo, Antonino DE LORENZO, David Mikeladze, Atefeh Khamoushi · 2020 · Current Molecular Medicine
79. Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes
    Chris E. Shannon, Méabh B. Ní Chathail, Sinéad M. Mullin, Andrew Meehan, Fiona C. McGillicuddy, Helen M. Roche · 2023 · Reviews in Endocrine and Metabolic Disorders
80. Diabetes Pharmacotherapy in 2012: Considerations in Medication Selection
    Susan A. Cornell, Vincent Dorsey · 2012 · Postgraduate Medicine
81. Testosterone and modifiable risk factors associated with diabetes in men
    Evan EA Atlantis, Kylie M. Lange, Sean Martin, Matthew T. Haren, Anne Winifred Taylor, Peter D. O’Loughlin, Villis R. Marshall, Gary Wittert · 2011 · Maturitas
82. Metabolic effects of muraglitazar in type 2 diabetic subjects
    M. Fernandez, Amalia Gastaldelli, Curtis L. Triplitt, Jean Hardies, Arturo Casolaro, Roberta Petz, Puntip Tantiwong, Nicolas Musi, Eugênio Cersósimo, Ele Ferrannini et al. · 2011 · Diabetes Obesity and Metabolism
83. Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
    Yu‐Hsin Chen, Der‐Cherng Tarng, Harn-Shen Chen · 2016 · PLoS ONE
84. Dietarysn-2 palmitic triacylglycerols reduced faecal lipids, calcium contents and altered lipid metabolism in Sprague–Dawley rats
    Puyu Yang, Hong Zhang, Jianchun Wan, Jinyu Hu, Junchen Liu, Jing Wang, Yaqiong Zhang, Liangli Lucy Yu · 2018 · International Journal of Food Sciences and Nutrition
85. [Leptin and its association with obesity and type 2 diabetes].
    Julio Cesar Almanza-Pérez, Gerardo Blancas‐Flores, Rebeca García-Macedo, Francisco Javier Alarcón-Aguilar, Miguel Cruz · 2008 · PubMed
86. Lignosulfonic acid promotes hypertrophy in 3T3-L1 cells without increasing lipid content and increases their 2-deoxyglucose uptake
    Yasushi Hasegawa, Erina Nakagawa, Yukiya Kadota, Satoshi Kawaminami · 2016 · Asian-Australasian Journal of Animal Sciences
87. Is the Amount of Coronary Perivascular Fat Related to Atherosclerosis?
    Ivana Králová Lesná, Zbyněk Tonar, Ines Malek, Jana Malušková, Lukáš Nedorost, Jan Pirk, Jan V Pitha, Věra Lánská, R. Poledne · 2015 · Physiological Research
88. Impact of Incretin Therapy on Islet Dysfunction: An Underlying Defect in the Pathophysiology of Type 2 Diabetes
    Janet B. McGill · 2009 · Postgraduate Medicine
89. Pioglitazone in diabetic kidney disease: forgotten but not gone
    Georgios S. Papaetis · 2022 · Archives of Medical Science - Atherosclerotic Diseases
90. Application of High-Resolution1H MAS NMR Spectroscopy to the Analysis of Intact Bones from Mice Exposed to Gamma Radiation
    Qibin Zhang, Jian Zhi Hu, Donald N. Rommereim, Mark K. Murphy, Richard P. Phipps, David L. Huso, John F. Dicello · 2009 · Radiation Research
91. RESISTENSI INSULIN TERKAIT OBESITAS: MEKANISME ENDOKRIN DAN INTRINSIK SEL
    Mira Dewi · 2007 · Jurnal Gizi dan Pangan
92. Quantifying the contribution of triglycerides to metabolic resilience through the mixed meal model
    Shauna D. O’Donovan, Balázs Erdõs, Doris M. Jacobs, Anne J. Wanders, Elizabeth Louise Thomas, Jimmy David Bell, Milena Rundle, Gary Steven Frost, Ilja C.W. Arts, Lydia A. Afman et al. · 2022 · iScience
93. The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
    Kenneth J. Cusi · 2009 · Humana Press eBooks
94. Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications
    Sandeep Kumar Mathur, Priyanka Jain, Prashant Mathur · 2011 · Journal of Obesity
95. N,N′-diphenethylurea isolated from Okinawan ascidian Didemnum molle enhances adipocyte differentiation in 3T3-L1 cells
    Sun‐Sil Choi, Byung‐Yoon Cha, Kagami Iida, Young-sil Lee, Hiroaki Sasaki, Kiyotake Suenaga, Toshiaki Teruya, Takayuki Yonezawa, Kazuo Nagai, Je-Tae Woo · 2011 · The Journal of Antibiotics
96. Role of Free Fatty Acids in Physiological Conditions and Mitochondrial Dysfunction
    ZBIGNIEW K. BINIENDA, Sumit Sarkar, Ana Sonia Silva‐Ramírez, Carmen González · 2013 · Food and Nutrition Sciences
97. Marine oils: Complex, confusing, confounded?
    Benjamin B. Albert, David Cameron‐Smith, Manohar L. Garg, José G. B. Derraik, Paul Leslie Hofman, Wayne S. Cutfield · 2016 · Journal of Nutrition & Intermediary Metabolism
98. Insulin ActionsIn Vivo: Glucose Metabolism
    Ele Ferrannini, Ralph A. DeFronzo · 2004 · Wiley eBooks
99. Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity
    Kaori Kitaoka, Ayaka Tsuboi, Satomi Minato-Inokawa, Mari Honda, Mika Takeuchi, Megumu Yano, Miki Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo · 2020 · BMJ Open Diabetes Research & Care
100. Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences
     Gianfranco Di Giuseppe, Gea Ciccarelli, CHIARA MARIA ASSUNTA CEFALO, Francesca Cinti, Simona Moffa, Flavia Impronta, Umberto Capece, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza · 2021 · Minerva Endocrinology